These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2139592)
21. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437 [TBL] [Abstract][Full Text] [Related]
22. Atrial natriuretic factor in the ascitic fluid of cirrhotic patients. Vesely DL; Winters CJ J Med; 1989; 20(3-4):208-16. PubMed ID: 2530296 [TBL] [Abstract][Full Text] [Related]
23. [The significance of clinical findings in evaluating the degree of portal hypertension in patients with liver cirrhosis]. Jedlicka J; Petrtýl J; Tesar V; Marecek Z; Cervinka J; Kordac V Cas Lek Cesk; 1989 Aug; 128(33):1035-9. PubMed ID: 2790908 [TBL] [Abstract][Full Text] [Related]
24. [Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]. Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D Gastroenterol Clin Biol; 1989; 13(8-9):701-6. PubMed ID: 2680727 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin. Ganger DR; Gottstein J; Blei AT J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Navasa M; Feu F; García-Pagán JC; Jiménez W; Llach J; Rimola A; Bosch J; Rodés J Hepatology; 1993 Mar; 17(3):355-60. PubMed ID: 8444409 [TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic factor in liver cirrhosis--the influence of volume expansion. Tesar V; Horký K; Petrýl J; Kozáková M; Gregorová I; Brodanová M; Kordac V; Hirsa M Horm Metab Res; 1989 Sep; 21(9):519-22. PubMed ID: 2531115 [TBL] [Abstract][Full Text] [Related]
28. New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state. Kimer N; Goetze JP; Bendtsen F; Møller S Eur J Clin Invest; 2014 May; 44(5):441-52. PubMed ID: 24476551 [TBL] [Abstract][Full Text] [Related]
29. [Studies on wedged hepatic venous pressure, hemodynamics and pulmonary function in patients with chronic liver disease, with reference to the differences between liver cirrhosis with chronic hepatitis]. Kurata F; Hara F Nihon Ika Daigaku Zasshi; 1991 Aug; 58(4):61-73. PubMed ID: 1918274 [TBL] [Abstract][Full Text] [Related]
33. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Ginès P; Jiménez W; Arroyo V; Navasa M; López C; Titó L; Serra A; Bosch J; Sanz G; Rivera F Hepatology; 1988; 8(3):636-42. PubMed ID: 2967242 [TBL] [Abstract][Full Text] [Related]
34. Atrial natriuretic factor in cirrhosis: relationship to renal function and hemodynamic changes. Fernández-Rodriguez C; Prieto J; Quiroga J; Zozaya JM; Andrade A; Rodriguez-Martinez D J Hepatol; 1994 Aug; 21(2):211-6. PubMed ID: 7989711 [TBL] [Abstract][Full Text] [Related]
35. Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade. Bendtsen F; Gerbes AL; Henriksen JH Scand J Clin Lab Invest; 1993 Oct; 53(6):547-54. PubMed ID: 8265999 [TBL] [Abstract][Full Text] [Related]
36. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. Møller S; Gülberg V; Henriksen JH; Gerbes AL J Hepatol; 1995 Aug; 23(2):135-44. PubMed ID: 7499784 [TBL] [Abstract][Full Text] [Related]
37. Hepato-systemic gradient of carbon monoxide in cirrhosis. Tarquini R; Masini E; La Villa G; Mazzoccoli G; Mastroianni R; Romanelli RG; Vizzutti F; Arena U; Santosuosso U; Laffi G Eur J Intern Med; 2012 Jan; 23(1):e14-8. PubMed ID: 22153542 [TBL] [Abstract][Full Text] [Related]
38. Plasma concentrations of interferon-alpha in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Wang YY; Chu CJ; Lee FY; Chang FY; Lin HC; Lu RH; Chan CC; Wang TF; Wang SS; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):195-202. PubMed ID: 10367479 [TBL] [Abstract][Full Text] [Related]
39. Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide. Henriksen JH; Gülberg V; Gerbes AL; Bendtsen F; Møller S Scand J Gastroenterol; 2003 May; 38(5):559-64. PubMed ID: 12795471 [TBL] [Abstract][Full Text] [Related]
40. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Henriksen JH; Christensen NJ; Ring-Larsen H Clin Physiol; 1981 Jun; 1(3):293-304. PubMed ID: 7199989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]